Solstein Capital’s Merck MRK Stock Holding History

Solstein Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.7K	Buy	+255	New	+$29.4K	0.01%	261
2025 Q3	–	Sell	-176	Closed	-$13.9K	–	492
2025 Q2	$13.9K	Buy	+176	New	+$14K	0.01%	310
2022 Q4	–	Sell	-700	Closed	-$60K	–	308
2022 Q3	$60K	Hold	700	–	–	0.05%	144
2022 Q2	$64K	Hold	700	–	–	0.05%	164
2022 Q1	$57K	Hold	700	–	–	0.04%	181
2021 Q4	$54K	Hold	700	–	–	0.03%	206
2021 Q3	$53K	Hold	700	–	–	0.03%	225
2021 Q2	$54K	Sell	700 -34	-5%	-$2.53K	0.07%	212
2021 Q1	$54K	Buy	+734	New	+$54.1K	0.07%	197
2020 Q4	–	Sell	-734	Closed	-$58K	–	161
2020 Q3	$58K	Hold	734	–	–	0.13%	123
2020 Q2	$54K	Hold	734	–	–	0.13%	108
2020 Q1	$54K	Sell	734 -2,162	-75%	-$170K	0.21%	77
2019 Q4	$251K	Buy	+2,896	New	+$238K	0.51%	46

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Solstein Capital's MRK Position: Q1 2026 in Review

Solstein Capital opened a new position in Merck (MRK) in Q1 2026: 255 shares worth $30.7K. The stake represents 0.01% of the portfolio and ranks #261 among its holdings. This is a return to the name: Solstein Capital previously reported a position in MRK as recently as Q2 2025.

Solstein Capital first reported a position in MRK in Q4 2019 and has held it in 13 quarters since. The position peaked at $251K in Q4 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Solstein Capital held 255 shares of Merck worth $30.7K as of Q1 2026.
Merck was a new Solstein Capital position in Q1 2026.
Merck made up 0.01% of Solstein Capital's portfolio in Q1 2026, its #261 holding.
Solstein Capital first reported a position in Merck in Q4 2019 and has held it in 13 quarters since.
Solstein Capital's Merck position peaked at $251K in Q4 2019.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.